Advertisement

Efficient Hepatic Differentiation of Human Induced Pluripotent Stem Cells in a Three-Dimensional Microscale Culture

  • Ran-Ran Zhang
  • Takanori TakebeEmail author
  • Leina Miyazaki
  • Maho Takayama
  • Hiroyuki Koike
  • Masaki Kimura
  • Masahiro Enomura
  • Yun-Wen Zheng
  • Keisuke Sekine
  • Hideki Taniguchi
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1210)

Abstract

Human induced pluripotent stem cells (iPSCs) represent a novel source of hepatocytes for drug development, disease modeling studies, and regenerative therapy for the treatment of liver diseases. A number of protocols for generating functional hepatocytes have been reported worldwide; however, reproducible and efficient differentiation remained challenging under conventional two-dimensional (2D) culture. In this study, we describe an efficient differentiation protocol for generating functional hepatocyte-like cells from human iPSC-derived homogenous hepatic endoderm cells combined with three-dimensional (3D) microscale culture system. First, hepatic endoderm cells (iPSC-HEs) were directly differentiated using two-step approaches, and then cultured in the 3D micropattern plate. Human iPSC-HEs quickly reaggregated and formed hundreds of round-shaped spheroids at day 4 of cell plating. The size distribution of iPSC-HEs derived spheroids was relatively uniform around 100–200 μm in diameter. After 14 days, iPSC-HEs efficiently differentiated into hepatocyte-like cells in terms of hepatic maker gene expression compared with conventional 2D approach. We conclude that our scalable and three-dimensional culture system would be one promising approach to generate a huge number of hepatocyte-like cells from human iPSCs aiming at future industrial and clinical applications.

Key words

Human induced pluripotent stem cells Hepatocyte-like cells Three-dimensional culture Spheroid 

Notes

Acknowledgements

We thank F. Kawamata, S Funayama, N. Hijikata, and N. Sasaki for kindly providing technical support; Y. Ueno and all of the members of our laboratory for help with several comments. This work was supported by the Grants-in-Aid of the Ministry of Education, Culture, Sports, Science, and Technology of Japan to T. Takebe (no. 24106510, 24689052), N. Koike (no. 22390260), and H. Taniguchi (no. 21249071, 25253079). This work was also supported by grants to H. Taniguchi from the Strategic Promotion of Innovative Research and Development (S-innovation, 62890004) of the Japan Science and Technology Agency (JST); by the Specified Research Grant of the Takeda Science Foundation and a grant from the Japan IDDM network to H. Taniguchi; and by a grant of the Yokohama Foundation for Advanced Medical Science to T. Takebe.

References

  1. 1.
    Schuster D, Laggner C, Langer T (2005) Why drugs fail-a study on side effects in new chemical entities. Curr Pharm Des 11(27):3545–3559PubMedCrossRefGoogle Scholar
  2. 2.
    Suzuki A, Andrade RJ, Bjornsson E, Lucena MI, Lee WM, Yuen NA, Hunt CM, Freston JW (2010) Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase™. Drug Saf 33(6):503–522PubMedCrossRefGoogle Scholar
  3. 3.
    Wilkening S, Bader A (2003) Influence of culture time on the expression of drug‐metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2. J Biochem Mol Toxicol 17(4):207–213PubMedCrossRefGoogle Scholar
  4. 4.
    Wilkening S, Stahl F, Bader A (2003) Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos 31(8):1035–1042PubMedCrossRefGoogle Scholar
  5. 5.
    Sharma R, Greenhough S, Medine CN, Hay DC (2010) Three-dimensional culture of human embryonic stem cell derived hepatic endoderm and its role in bioartificial liver construction. J Biomed Biotechnol 2010:1–12. doi: 10.1155/2010/236147 Google Scholar
  6. 6.
    Frye RF, Zgheib NK, Matzke GR, Chaves-Gnecco D, Rabinovitz M, Shaikh OS, Branch RA (2006) Liver disease selectively modulates cytochrome P450-mediated metabolism. Clin Pharmacol Ther 80(3):235–245PubMedCrossRefGoogle Scholar
  7. 7.
    Lee WM (2003) Drug-induced hepatotoxicity. N Engl J Med 349(5):474–485PubMedCrossRefGoogle Scholar
  8. 8.
    Pelkonen O, Mäeenpäeä J, Taavitsainen P, Rautio A, Raunio H (1998) Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 28(12):1203–1253PubMedCrossRefGoogle Scholar
  9. 9.
    Acikgöz A, Giri S, Cho M-G, Bader A (2013) Morphological and functional analysis of hepatocyte spheroids generated on poly-HEMA-treated surfaces under the influence of fetal calf serum and nonparenchymal cells. Biomolecules 3(1):242–269. doi: 10.3390/biom3010242 PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Xiong A, Austin TW, Lagasse E, Uchida N, Tamaki S, Bordier BB, Weissman IL, Glenn JS, Millan MT (2008) Isolation of human fetal liver progenitors and their enhanced proliferation by three-dimensional coculture with endothelial cells. Tiss Eng A 14(6):995–1006CrossRefGoogle Scholar
  11. 11.
    Zamule SM, Coslo DM, Chen F, Omiecinski CJ (2011) Differentiation of human embryonic stem cells along a hepatic lineage. Chem Biol Interact 190(1):62–72. doi: 10.1016/j.cbi.2011.01.009 PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872PubMedCrossRefGoogle Scholar
  13. 13.
    Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676PubMedCrossRefGoogle Scholar
  14. 14.
    Genbacev O, Krtolica A, Zdravkovic T, Brunette E, Powell S, Nath A, Caceres E, McMaster M, McDonagh S, Li Y (2005) Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders. Fertil Steril 83(5):1517–1529PubMedCrossRefGoogle Scholar
  15. 15.
    Stephenson E, Jacquet L, Miere C, Wood V, Kadeva N, Cornwell G, Codognotto S, Dajani Y, Braude P, Ilic D (2012) Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment. Nat Protoc 7(7):1366–1381PubMedCrossRefGoogle Scholar
  16. 16.
    Takayama K, Kawabata K, Nagamoto Y, Kishimoto K, Tashiro K, Sakurai F, Tachibana M, Kanda K, Hayakawa T, Furue MK, Mizuguchi H (2013) 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing. Biomaterials 34(7):1781–1789. doi: 10.1016/j.biomaterials.2012.11.029 PubMedCrossRefGoogle Scholar
  17. 17.
    Xia L, Sakban RB, Qu Y, Hong X, Zhang W, Nugraha B, Tong WH, Ananthanarayanan A, Zheng B, Chau IY-Y, Jia R, McMillian M, Silva J, Dallas S, Yu H (2012) Tethered spheroids as an in vitro hepatocyte model for drug safety screening. Biomaterials 33(7):2165–2176. doi: 10.1016/j.biomaterials.2011.12.006 PubMedCrossRefGoogle Scholar
  18. 18.
    Duan Y, Catana A, Meng Y, Yamamoto N, He S, Gupta S, Gambhir SS, Zern MA (2007) Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Stem Cells 25(12):3058–3068PubMedCrossRefGoogle Scholar
  19. 19.
    Chen YF, Tseng CY, Wang HW, Kuo HC, Yang VW, Lee OK (2012) Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol. Hepatology 55(4):1193–1203PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, North PE, Dalton S, Duncan SA (2010) Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51(1):297–305PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Ogawa S, Surapisitchat J, Virtanen C, Ogawa M, Niapour M, Sugamori KS, Wang S, Tamblyn L, Guillemette C, Hoffmann E (2013) Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. Development 140(15):3285–3296PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Kawasaki H, Suemori H, Mizuseki K, Watanabe K, Urano F, Ichinose H, Haruta M, Takahashi M, Yoshikawa K, Nishikawa S-I (2002) Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc Natl Acad Sci 99(3):1580–1585PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, Zhang R-R, Ueno Y, Zheng Y-W, Koike N (2013) Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499(7459):481–484PubMedCrossRefGoogle Scholar
  24. 24.
    Takebe T, Sekine K, Suzuki Y, Enomura M, Tanaka S, Ueno Y, Zheng YW, Taniguchi H (2012) Self-organization of human hepatic organoid by recapitulating organogenesis in vitro. Transplant Proc 44(4):1018–1020PubMedCrossRefGoogle Scholar
  25. 25.
    Takebe T, Zhang R-R, Koike H, Kimura M, Yoshizawa E, Enomura M, Koike N, Sekine K, Taniguchi H (2014) Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature Protocols 9(2):396–409Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Ran-Ran Zhang
    • 1
  • Takanori Takebe
    • 1
    Email author
  • Leina Miyazaki
    • 1
  • Maho Takayama
    • 1
  • Hiroyuki Koike
    • 1
  • Masaki Kimura
    • 1
  • Masahiro Enomura
    • 1
  • Yun-Wen Zheng
    • 1
  • Keisuke Sekine
    • 1
  • Hideki Taniguchi
    • 1
  1. 1.Department of Regenerative MedicineYokohama City University Graduate School of MedicineYokohamaJapan

Personalised recommendations